Beneficial Effect of  Ultra-Low-Dose  Aspirin in Platelet Activity Alterations and Haemorrhage Observed in Experimental Portal Hypertension

<table>Study of Hematocrit (expressed in %): Control: Sham operated rats. Cont + ULDA: Sham operated rats pretreated with ULDA. Cirrh: Cirrhotic rats. Cirrh + ULDA: Cirrhotic rats pretreated with ULDA. <sup>a</sup><svg height="11.375" id="M8" style="vertical-align:-0.1638pt" version="1.1" viewbox="0 0 58.712502 11.375" width="58.712502" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,11.112)"><use xlink:href="#x1D443"></use></g><g transform="matrix(.017,-0,0,-.017,15.582,11.112)"><use xlink:href="#x3C"></use></g><g transform="matrix(.017,-0,0,-.017,30.286,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,38.446,11.112)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,42.321,11.112)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,50.481,11.112)"><use xlink:href="#x31"></use></g>
</svg> versus Control. (ANOVA, Bonferroni post-test).</table>

Thrombosis

fig5

Figure 5

Figure 5: Beneficial Effect of  Ultra-Low-Dose  Aspirin in Platelet Activity Alterations and Haemorrhage Observed in Experimental Portal Hypertension 

Figure 5 | Beneficial Effect of  Ultra-Low-Dose  Aspirin in Platelet Activity Alterations and Haemorrhage Observed in Experimental Portal Hypertension 